Skip to main content
. 2015 Nov 6;10(11):e0142141. doi: 10.1371/journal.pone.0142141

Table 1. Comparison between Control, CRCRTR-MACE <10% and CRCRTR-MACE ≥20%.

Marker Control MACE < 10% MACE ≥ 20% P1 P2 P3 P4
IL6 6.53pg/mL(0.08–58.98) 6.36 pg/mL (0.3–139.31) 9.63 pg/mL (0.3–167.58) 0.140 0.490 0.036 0.134
IL8 8.7 pg/mL (0.08–42.28) 11.95 pg/mL (2.85–103.21) 13.52 pg/mL (3.7–495.97) 0.046 0.088 0.049 0.348
IL9 18.37 pg/mL (0.65–71.8) 23.46 pg/mL (1.72–357.38) 25.11 pg/mL (5.99–165.57) 0.108 0.109 0.033 0.328
IL15 2.5 pg/mL (0.59–25.1) 5.2 pg/mL (1.52–20.01) 4.09 pg/mL (1.52–42.79) 0.012 0.003 0.010 0.784
IL16 64.22 pg/mL (5.16–527.73) 88.54 pg/mL (20.57–720.69) 75.28 pg/mL (9.77–392.43) 0.410 0.018 0.114 0.571
IL17 31.74 pg/mL (0.09–126.13) 37.46 pg/mL (0.09–167.3) 46.55±27.00 pg/mL 0.250 0.240 0.042 0.451
IL20 62.48 pg/mL (18.71–528.16) 195.02 pg/mL (48.8–844.45) 75.05 pg/mL (48.8–806.74) 0.001 0.001 0.032 0.419
IL21 17.37 pg/mL (3.27–30.92) 19.53 pg/mL (3.8–39.74) 19.53 pg/mL (3.21–30.18) 0.004 0.002 0.031 0.809
IL33 19.53 pg/mL (0.14–150.91) 19.53 pg/mL (0.14–53.75) 32.37 pg/mL (0.14–337.65) 0.000 0.108 0.002 0.005
IFN-γ 71.54 pg/mL (0.07–2886.64) 67.5 pg/mL (0.07–1818.3) 102.62 pg/mL (0.07–1432.36) 0.003 0.288 0.637 0.279

P1 is the p value between the three groups: control, CRCRTR-MACE <10% and CRCRTR-MACE ≥20%, (P1 was computed by one-way ANOVA); P2 is the p value between control and CRCRTR-MACE <10%; P3 is the p value between control and CRCRTR-MACE ≥20%; P4 is the p value between CRCRTR-MACE <10% and CRCRTR-MACE ≥20% (P2,P3&P4 were computed by Mann-Whitney U-test).

Note the following interleukins were not significant in the analysis: IL1a, IL1b, IL2, IL4, IL5, IL7, IL10, IL12p70, IL13, IL23, IL23A, TNF-α (full results shown in appendix 1)